![Sodium (6R,7R)-7-[[(2Z)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-(hydroxyimino)acetyl]amino]-3-[(E)-[(3…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fcas-image%2Fthumb-webp%2F313605-sodium-6r-7r-7-2z-2-5-amino-124-thiadiazol-3-yl-2-hydroxyimino-acetyl-amino-3-e-3r-1-5-methyl-2-oxo-13-dioxol-4-yl-methoxy-carbonyl-2-oxo-13-bipyrrolidin-3-ylidene-methyl-8-oxo-5-thia-1-azabicyclo-4-2-0-oct-2-ene-2-carboxylate-1-1.webp&w=3840&q=75)
CAS 252188-71-9: Sodio (6R,7R)-7-[[(2Z)-2-(5-amino-1,2,4-tiadiazol-3-il)-2-(hidroximino)acetil]amino]-3-[(E)-[(3′R)-1′-[[(5-metil-2-oxo-1,3-dioxol-4-il)metoxi]carbonil]-2-oxo[1,3′-bipirrolidin]-3-ilideno]metil]-8-oxo-5-tia-1-azabiciclo[4.2.0]oct-2-eno-2-carboxilato (1:1)
Descripción:
La sustancia química conocida como Sodio (6R,7R)-7-[[[2Z]-2-(5-amino-1,2,4-tiadiazol-3-il)-2-(hidroxiimino)acetilo]amino]-3-[(E)-[(3′R)-1′-[[(5-metil-2-oxo-1,3-dioxol-4-il)metoxi]carbonilo]-2-oxo[1,3′-bipirrolidina]-3-ilideno]metilo]-8-oxo-5-tia-1-azabiciclo[4.2.0]oct-2-eno-2-carboxilato (1:1) es un compuesto orgánico complejo caracterizado por su intrincada estructura, que incluye múltiples grupos funcionales como amino, hidroxiimino y carboxilato. Este compuesto presenta una estructura central bicíclica, indicativa de su potencial actividad biológica. La presencia de un anillo de tiadiazole sugiere posibles propiedades antimicrobianas, mientras que los grupos oxo y dioxol pueden contribuir a su reactividad y estabilidad. Como sal de sodio, es probable que sea soluble en agua, lo que puede mejorar su biodisponibilidad para aplicaciones farmacéuticas. La estereoquímica específica del compuesto, denotada por la configuración (6R,7R), puede influir en su interacción con objetivos biológicos, convirtiéndolo en un tema de interés en química medicinal y desarrollo de fármacos. En general, esta sustancia ejemplifica la complejidad y diversidad de los compuestos orgánicos sintéticos modernos utilizados en contextos terapéuticos.
Fórmula:C26H26N8O11S2·Na
InChI:InChI=1S/C26H26N8O11S2.Na/c1-10-14(45-26(41)44-10)8-43-25(40)32-4-3-13(7-32)33-5-2-11(20(33)36)6-12-9-46-22-16(21(37)34(22)17(12)23(38)39)28-19(35)15(30-42)18-29-24(27)47-31-18;/h6,13,16,22,42H,2-5,7-9H2,1H3,(H,28,35)(H,38,39)(H2,27,29,31);/b11-6+,30-15-;/t13-,16-,22-;/m1./s1
Clave InChI:InChIKey=BYUIXTXYXHAECA-LCJFHXTKSA-N
SMILES:C(O)(=O)C=1N2[C@@]([C@H](NC(/C(=N\O)/C=3N=C(N)SN3)=O)C2=O)(SCC1/C=C\4/C(=O)N(CC4)[C@H]5CN(C(OCC=6OC(=O)OC6C)=O)CC5)[H].[Na]
Sinónimos:- 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2Z)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-(hydroxyimino)acetyl]amino]-3-[(E)-[(3′R)-1′-[[(5-methyl-2-oxo-1,3-dioxol-4-yl)methoxy]carbonyl]-2-oxo[1,3′-bipyrrolidin]-3-ylidene]methyl]-8-oxo-, sodium salt (1:1), (6R,7R)-
- Ro 65-5788
- Sodium (6R,7R)-7-[[(2Z)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-(hydroxyimino)acetyl]amino]-3-[(E)-[(3′R)-1′-[[(5-methyl-2-oxo-1,3-dioxol-4-yl)methoxy]carbonyl]-2-oxo[1,3′-bipyrrolidin]-3-ylidene]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate (1:1)
- 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2Z)-(5-amino-1,2,4-thiadiazol-3-yl)(hydroxyimino)acetyl]amino]-3-[(E)-[(3′R)-1′-[[(5-methyl-2-oxo-1,3-dioxol-4-yl)methoxy]carbonyl]-2-oxo[1,3′-bipyrrolidin]-3-ylidene]methyl]-8-oxo-, monosodium salt, (6R,7R)-
- Sodium (6R,7R)-3-((E)-(1-((R)-1-(((5-methyl-2-oxo-1,3-dioxol-4-yl)methoxy)carbonyl)pyrrolidin-3-yl)-2-oxopyrrolidin-3-ylidene)methyl)-7-((Z)-2-(5-amin
- BAL 5788
- Ceftobiprole medocaril sodium
- Ceftobiprole Medocaril Sodium Sterile Powder
Ordenar por
Encontrado 2 productos.
Ceftobiprole medocaril sodium
CAS:Ceftobiprole medocaril sodium is a broad-spectrum cephalosporin antibiotic, which is a synthetically derived prodrug of ceftobiprole. Upon administration, ceftobiprole medocaril is rapidly converted into its active form, ceftobiprole, by the body's endogenous esterases. The mode of action involves binding to penicillin-binding proteins (PBPs) in the bacterial cell wall, leading to the inhibition of cell wall synthesis and ultimately the death of the bacteria. This action is effective against a wide range of gram-positive and gram-negative bacteria, including methicillin-resistant Staphylococcus aureus (MRSA) and penicillin-resistant Streptococcus pneumoniae. Ceftobiprole medocaril sodium is primarily used in the treatment of complex skin and soft tissue infections, as well as community-acquired and hospital-acquired pneumonia. Its broad-spectrum efficacy makes it a critical tool in environments where multi-drug resistant bacterial strains are prevalent. The development of ceftobiprole medocaril was driven by the urgent need for effective antibiotics against resistant pathogens, enabling it to play a vital role in modern infectious disease management and antimicrobial stewardship.Fórmula:C26H26N8O11S2NaPureza:Min. 95%Peso molecular:713.65 g/molCeftobiprole medocaril sodium
CAS:Ceftobiprole medocaril sodium (BAL5788) is a prodrug of broad-spectrum cephalosporin active against MRSA, VRSA, and resistant streptococci.Fórmula:C26H25N8NaO11S2Forma y color:SolidPeso molecular:712.64
